Cost-Effectiveness Analysis Of Antidiabetic Medications In Patients With Type 2 Diabetes Mellitus At Rajawali Citra Hospital
Abstract
Indonesia ranks fourth in the world for the number of individuals with diabetes mellitus (DM). To manage this growing health concern, it is crucial to implement treatments that include pharmacological therapies, such as antidiabetic. This study aims to identify the most cost-effective type of antidiabetic drug for patients with type 2 diabetes mellitus, based on the Average Cost-Effectiveness Ratio values.
This study was a descriptive observational study that utilized medical records of outpatients with Type 2 Diabetes Mellitus at Rajawali Citra Hospital from 2023 to 2025, involving a total of 52 participants who met the criteria. The sampling technique employed was purposive sampling. Data analysis included demographic and clinical characteristics, factors influencing glycemic control, therapy cost components, and cost-effectiveness based on ACER values.
The results indicated that the majority of diabetes patients were over the age of 45 (94.2%), with 67.3% being female. For BPJS patients, the most effective and cost-effective treatment was thiazolidinedione used as monotherapy, while the combination of metformin and acarbose proved to be the most effective. For the non-insured patients with type 2 diabetes, sulfonylurea was the most effective treatment as monotherapy, and the combination of sulfonylurea and acarbose was the most effective for combination therapy.
References
A, B., Tao J, Tao L & Liu J, 2021. Prevalence and risk factors of diabetes among adults aged 45 years or older in China: A national cross-sectional study. Issue 24;4(3.
Alam, F. et al., 2019. Efcacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Scientific Reports.
Andriani, E., Haskas, Y. & Mutmainna, A., 2021. Hubungan Kontrol Glikemik Dan Kepatuhan Pengobatan Dengan Kejadian Hospital Readmission Pada Pasien Diabetes Melitus. Jurnal Ilmiah Mahasiswa & Penelitian Keperawatan .
Apriandy, M. A., 2022. Analisis efektivitas biaya terapi antidiabetes pada pasien prolanis diabetes melitus tipe 2 puskesmas Salewangen Kab Wajo. Skripsi. Fakultas kedokteran dan ilmu kesehatan:UIN Alaudiin Makasar.
Arnetz, L., N, R. E. & M, A., 2014. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes..
Badan Penelitian dan Pengembangan Republik Indonesia, 2023. [Online]
Available at: http://kesnas.kemkes.go.id/
Badan Pusat Statistik, 2023. Profil Statistik Kesehatan 2023. 7 penyunt. Jakarta: Badan Pusat Statistik.
Badan Pusat Statistik, 2025. Suku Bunga Kredit Rupiah Menurut Kelompok Bank 2023-2024. [Online] Available at: https://www/bps.go,id [Diakses 31 Juli 2025].
Baroroh, F., Solikah, W. Y. & Urfiyya, Q. . ‘., 2016. ANALISIS BIAYA TERAPI DIABETES MELITUS TIPE 2 DI RUMAH SAKIT PKU MUHAMMADIYAH BANTUL YOGYAKARTA. Jurnal Farmasi Sains dan Praktis, Issue Vol. I, No. 2.
Boye, K. Thieu.V.T., Lage, M.J., Miller, H., 2022. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study. Adv Ther, Issue 39(5), pp. 2208-2221.
Direktorat Jenderal Pencegahan dan Pengendalian Penyakit, 2019. Buku pedoman penyakit tidak menular. Kementerian Kesehatan RI.
Fahmi, K. N. & Urfiyya, Q. A., 2022. An Overview Insulin Used In Outpatient With Diabetes Mellitus Type 2 At Hidayatullah Islamic Yogyakarta Hospital.. Jurnal Inovasi Farmasi Indonesia (JAFI), Issue 4(1), pp. 12-21.
IDF, 2011. IDF Diabetes Atlas Fifth Edition. IDF.
IDF, 2019. IDF Diabetes Atlas Ninth Edition. In The Lancet , p. 266.
Ivana, K., Dhigna Luthfiyani Citra Pradana & Citra Ayu April, 2022. Narrative Review: Cost-Effectiveness Analysis Of Biguanide And Sulfonylureafor Hospitalized Patientwith Type 2 Diabetes Mellitus. journal of Research in Pharmacy and Pharmaceutical Sciences.
Jannah, E. N., Ismunandar, A. & Maulana, L. H., 2021. Analisis Efektivitas Biaya Penggunaan Antidiabetik Oral pada Pasien Diabetes Mellitus Tipe 2 Rawat Jalan Peserta Bpjs di RSUD Bumiayu 2020. Pharmacy Peradaban Journal.
Kemenkes, 2023. Survei Kesehatan Indonesia (SKI) 2023. s.l.:Badan Kebijakan Pembangunan Kesehatan (BKPK).
Laelasari, E., Saurisari, R. & Banun, A., 2017. Cost-effectiveness analysis of insulin, sulfonylurea, and sulfonylurea– Metformin in type 2 diabetes mellitus. Asian Journal of Pharmaceutical and Clinical Research .
Mamo, Y. & Bekele, F, 2019. Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study. BMC Endocr Disord, Issue 19(91).
McGill, J. et al., 2013. Effect of gender on treatment outcomes in type 2 diabetes mellitus.. Diabetes Res Clin Pract, Issue 102(3), pp. 167-74.
Patty, Y., Mufarrihah & Nita Y, 2021. Cost of illness of diabetes mellitus in Indonesia: a systematic review. J Basic Clin Physiol Pharmacol, Issue 25;32(4), pp. 285-295. doi: 10.1515/jbcpp-2020-0502. PMID: 34214313..
Perkumpulan Endokrinologi Indonesia (PERKENI), 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. (online): PB Perkeni.
RI, K. K., 2018. RISKESDAS Tahun 2018.
Sauenram, N., J, S., C, V. & P., S., 2023. Estimation of the onset time of diabetic complications in type 2 diabetes patients in Thailand: a survival analysis. Osong Public Health Res Perspect, Issue Dec;14(6):508-519. doi: 10.24171/j.phrp.
Sulastri, Perwitasari, D. A. & Supadmi, W., 2023. Analisis Efektivitas Biaya Penggunaan Metformin dan Metformin-Glimepirid Pada Pasien Diabetes Melitus Tipe 2 di DuaPuskesmas Kulon Progo Yogyakarta. Indonesian Journal of Pharmacy and Natural Product.
Urfiyya, Q. A., 2023. Pola Peresepan Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe 2 Di Puskesmas Tegalrejo Yogyakarta Periode Oktober-November 2022. Journal Pharmacopoeia, Issue 2(2), pp. 153-161.
Urfiyya, Q. A. & Aisyah, 2023. Pola Peresepan Antidiabetik Pasien Diabetes Melitus Tipe 2 Rawat Jalan di PKU Muhammadiyah Yogyakarta. AFAMEDIS, Issue 4(2), pp. 148-153.
Urfiyya, Q. A. & Aisyah, 2023. Rationality of Antidiabetic in Outpatient with Type 2 Diabetes Mellitus at PKU Muhammadiyah Yogyakarta Hospital, Special Region of Yogyakarta-Indonesia. Pharmacology and Clinical Pharmacy Research, Issue 8(2), pp. 138-145.
Urfiyya, Q. A. & Azizah, A. R., 2024. Evaluasi Penggunaan Antidiabetik Pasien Diabetes Melitus Tipe 2 di Puskesmas Banguntapan 1. Jurnal Sains dan Kesehatan, Issue Fakultas Farmasi Universitas Mulawarman.
Urfiyya, Q. '., Fatkhiya, M. F, Perwitasari, D. A & Febriana, S, 2022. Analisis biaya pasien Severe Cutaneous Adverse Reactions (SCARs). Jurnal Ilmiah Farmasi, Issue 18(2), 123-133..
Urfiyya, Q. '., Perwitasari, D. A & Febriana, S, 2020. Analisis Cost of Illness Stevens Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN). Jurnal Pharmascience, Issue 7(1), pp. 84-91.
World Health Organization, 2016. Global Report on Diabetes.. Geneva.
World Health Organization (WHO), 2023. https://www.who.int/health-topics/diabetes?gclid=Cj0KCQiAyKurBhD5ARIsALamXaHdwtiEnxkkziYgoWRkJiDeCpVPp0Bw7dnzYOpN5gDWQ7yahEV-ZY0aAv5XEALw_wcB#tab=tab_1. [Online].
Wulandari, N., Maifitrianti, Muthi'ah, F & Disya, N.N, 2021. Antidiabetic Regimen and Factors Associated with Glycemic Control in Patients with Type 2 Diabetes mellitus in Public Health Centers in Jakarta: A Cross-Sectional Study. JMPF.
Yu, Y. et al., 2020. The achievement of comprehensive control targets among type 2 diabetes mellitus patients of different ages.. Aging (Albany NY).
1.png){kind=small}
